Researchers identify key geographic and health factors that may predict the prevalence of antimicrobial-resistant gonorrhea in the United States.

Investment analysts at StockNews.com assumed coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the stock. Oragenics Stock ...

StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock.

"We are so happy to say that Glitch has made an amazing recovery and is now available for adoption!" SAHS said in its ...

Court documents say 24-year-old Aliyah Robyn Stalder bit a flight attendant on the hand, puncturing the skin and requiring ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the treatment of adults with complicated intra-abdominal infections (cIAI) with ...

Multidrug resistance has remarkably increased in many countries, which could limit the antibiotic options in ... 19A pneumococcal clones by its coverage of serotype 19A.

Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...

Britain's pharmacies regulator on Tuesday tightened rules for online pharmacies' prescribing obesity drugs, ordering them to make changes to prevent people from receiving drugs that could cause them ...

Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

TB infections have been rising every year since 2020 after 30 years of decline. Now, a historic outbreak in Kansas is ...